FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092734 [Registered on: 11/08/2025] Trial Registered Prospectively
Last Modified On: 09/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Homoeopathic Trail for Fungal Skin Infection in Young Adults: A Controlled Study 
Scientific Title of Study   An interventional study to evaluate the effectiveness of homoeopathic medicine based on the totality of symptoms in the treatment of Tinea corporis in young adults : A randomized placebo-controlled trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pooja Sangwan 
Designation  MD, PGR (post graduate resident) 
Affiliation  Swasthya Kalyan Homoeopathic Medical College and Research Centre Jaipur 
Address  Swasthya Kalyan Homoeopathic Medical College and Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura

Jaipur
RAJASTHAN
302022
India 
Phone  8901119516  
Fax    
Email  sangwan.tapash97@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Harish Jabdoliya 
Designation  Associate professor, Department of Organon of Medicine and Homoeopathic Philosophy 
Affiliation  Swasthya Kalyan Homoeopathic Medical College and Research Centre Jaipur 
Address  Swasthya Kalyan Homoeopathic Medical College and Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura

Jaipur
RAJASTHAN
302022
India 
Phone  9782910856  
Fax    
Email  harish10jabdoliya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Harish Jabdoliya 
Designation  Associate professor, Department of Organon of Medicine and Homoeopathic Philosophy 
Affiliation  Swasthya Kalyan Homoeopathic Medical College and Research Centre Jaipur 
Address  Swasthya Kalyan Homoeopathic Medical College and Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura

Jaipur
RAJASTHAN
302022
India 
Phone  9782910856  
Fax    
Email  harish10jabdoliya@gmail.com  
 
Source of Monetary or Material Support  
Swasthya Kalyan Homoeopathic Medical College And Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura Jaipur Rajasthan 302022 
 
Primary Sponsor  
Name  Swasthya Kalyan Homoeopathic Medical College And Research Centre 
Address  Swasthya Kalyan Homoeopathic Medical College And Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura Jaipur Rajasthan 302022 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pooja sangwan  Swasthya Kalyan Homoeopathic Medical College And Research Centre  Swasthya Kalyan Homoeopathic Medical College And Research Centre 10-A Sitapura Institutional Area Tonk Road Goner Road Sitapura Industrial Area Sitapura Jaipur Rajasthan 302022
Jaipur
RAJASTHAN 
8901119516

sangwan.tapash97@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SKHMCIEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B354||Tinea corporis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicine  2/UA/HPM/2011, oral route, doses and frequency will be according to susceptibility of patient 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  26.00 Year(s)
Gender  Both 
Details  Clinical Diagnosed of Tinea Corporis
 
 
ExclusionCriteria 
Details  Immuno-compromised patients such as suffering from HIV, Hepatitis B or C
Patients who are not willing to give informed consent
Patients taking other treatments
Cases with significant co-morbidities 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
cure rate or change in symptom score will be compared between groups  12 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/08/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a randomized, single-blind, placebo-controlled clinical trial conducted to evaluate the effectiveness of individualized homoeopathic medicines prescribed on the basis of totality of symptoms in the treatment of Tinea corporis among young adults. The study is being carried out at Swasthya Kalyan Homoeopathic Medical College and Research Centre, Jaipur.

A total of 60 participants aged 18–26 years, clinically diagnosed with Tinea corporis, will be randomly assigned to two groups: one receiving individualized homoeopathic treatment and the other receiving a placebo. Allocation will be done using sealed opaque envelopes, and participants will be blinded to their group assignment.

The primary outcome measures include clinical improvement in skin lesions and reduction in symptom intensity (e.g., pruritus), assessed over a period of 3 months. Secondary outcomes include improvement in quality of life using the Dermatology Life Quality Index (DLQI).

This study aims to bridge classical homoeopathic philosophy (miasmatic and individualistic prescription) with modern clinical research methodology, contributing to evidence-based validation of homoeopathic treatment in superficial fungal infections.

 
Close